EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieVergleichsstudie

Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial

Tomoe Abe, Yasutaka Takeda iD, Ichiro Sakuma, Mizuho Okada, Ayaka Kurigaki, Ryoichi Bessho, Mao Sato, Hiroya Kitsunai, Yumi Takiyama, Masaru Sakurai

Metabolic Syndrome and Related Disorders · 2024

DOI: 10.1089/met.2024.0127 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Metabolic Syndrome and Related Disorders, 2024. Verfasst von Tomoe Abe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metformin, Vildagliptin, Uracil. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2MetforminVildagliptinUracilBlood GlucoseGlycated HemoglobinDrug CombinationsHypoglycemic AgentsTabletsDipeptidyl-Peptidase IV InhibitorsGlycemic ControlPiperidinesHumansMiddle AgedFemaleMaleAgedAdultProspective StudiesTreatment OutcomeYoung AdultJapanPyrrolidines

Stichwörter der Autor:innen

combination tabletdipeptidyl peptidase-4 inhibitormetforminpharmacotherapytype 2 diabetes

Substanzen

MetforminVildagliptinUracilBlood GlucoseGlycated HemoglobinDrug CombinationsalogliptinHypoglycemic AgentsTabletsDipeptidyl-Peptidase IV Inhibitors

Autor:innen und Institutionen

  • Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
  • Sapporo Diabetes and Thyroid Clinic, Sapporo, Japan.
  • Department of Diabetology and Endocrinology, Kanazawa Medical University, Uchinada, Japan.
  • Caress Sapporo Hokko Memorial Clinic, Sapporo, Japan.
  • Keiyukai Yoshida Hospital, Asahikawa, Japan.
  • Department of Social and Environmental Medicine, Kanazawa Medical University, Uchinada, Japan.

ORCID-Profile: Yasutaka Takeda

Zitieren

APA

Abe, T., Takeda, Y., Sakuma, I., Okada, M., Kurigaki, A., Bessho, R., Sato, M., Kitsunai, H., Takiyama, Y., & Sakurai, M. (2024). Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial. Metabolic Syndrome and Related Disorders. https://doi.org/10.1089/met.2024.0127

Vancouver

Abe T, Takeda Y, Sakuma I, Okada M, Kurigaki A, Bessho R, et al. Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial. Metabolic Syndrome and Related Disorders. 2024. doi:10.1089/met.2024.0127

BibTeX
@article{Abe2024,
  author = {Abe, Tomoe and Takeda, Yasutaka and Sakuma, Ichiro and Okada, Mizuho and Kurigaki, Ayaka and Bessho, Ryoichi and Sato, Mao and Kitsunai, Hiroya and Takiyama, Yumi and Sakurai, Masaru},
  title = {Efficacy of Alogliptin/Metformin Fixed-Dose Combination Tablets and Vildagliptin/Metformin Fixed-Dose Combination Tablets on Glycemic Control in Real-World Clinical Practice for the Patients with Type 2 Diabetes: A Multicenter, Open-Label, Randomized, Parallel Group, Comparative Trial},
  journal = {Metabolic Syndrome and Related Disorders},
  year = {2024},
  doi = {10.1089/met.2024.0127}
}
Kostenlos starten →